Last update 21 Nov 2024
Pneumococcal polysaccharide vaccine 23-valent (Vacin Biomedicine)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Prophylactic vaccine, Multivalent vaccine |
Synonyms- |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with Pneumococcal polysaccharide vaccine 23-valent (Vacin Biomedicine)A Randomized, Blinded, Parallel Controlled Phase 3 Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People Aged 2 Years and Above
评价23价肺炎球菌多糖疫苗在2岁及以上健康人群中接种的免疫原性和安全性的随机、盲法、同类疫苗对照的III期临床试验
[Translation] A randomized, blinded, similar vaccine-controlled phase III clinical trial to evaluate the immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years and above
评价23价肺炎球菌多糖疫苗在2岁及以上人群接种的安全性和免疫原性的单中心、开放Ⅰ期临床试验
[Translation] A single-center, open-label phase I clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in people aged 2 years and above
100 Clinical Results associated with Pneumococcal polysaccharide vaccine 23-valent (Vacin Biomedicine)
Login to view more data
100 Translational Medicine associated with Pneumococcal polysaccharide vaccine 23-valent (Vacin Biomedicine)
Login to view more data
100 Patents (Medical) associated with Pneumococcal polysaccharide vaccine 23-valent (Vacin Biomedicine)
Login to view more data
100 Deals associated with Pneumococcal polysaccharide vaccine 23-valent (Vacin Biomedicine)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pneumococcal Infections | Phase 3 | CN | 07 Sep 2023 | |
| Pneumonia | Phase 3 | CN | 07 Sep 2023 | |
| Meningitis | Phase 1 | CN | 30 Dec 2021 | |
| Otitis Media | Phase 1 | CN | 30 Dec 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free